Molecular characterization of CTNS deletions in nephropathic cystinosis: development of a PCR-based detection assay - PubMed (original) (raw)

Molecular characterization of CTNS deletions in nephropathic cystinosis: development of a PCR-based detection assay

L Forestier et al. Am J Hum Genet. 1999 Aug.

Abstract

Nephropathic cystinosis is an autosomal recessive disorder that is characterized by accumulation of intralysosomal cystine and is caused by a defect in the transport of cystine across the lysosomal membrane. Using a positional cloning strategy, we recently cloned the causative gene, CTNS, and identified pathogenic mutations, including deletions, that span the cystinosis locus. Two types of deletions were detected-one of 9.5-16 kb, which was seen in a single family, and one of approximately 65 kb, which is the most frequent mutation found in the homozygous state in nearly one-third of cystinotic individuals. We present here characterization of the deletion breakpoints and demonstrate that, although both deletions occur in regions of repetitive sequences, they are the result of nonhomologous recombination. This type of mechanism suggests that the approximately 65-kb deletion is not a recurrent mutation, and our results confirm that it is identical in all patients. Haplotype analysis shows that this large deletion is due to a founder effect that occurred in a white individual and that probably arose in the middle of the first millenium. We also describe a rapid PCR-based assay that will accurately detect both homozygous and heterozygous deletions, and we use it to show that the approximately 65-kb deletion is present in either the homozygous or the heterozygous state in 76% of cystinotic patients of European origin.

PubMed Disclaimer

Similar articles

• The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion.
  Touchman JW, Anikster Y, Dietrich NL, Maduro VV, McDowell G, Shotelersuk V, Bouffard GG, Beckstrom-Sternberg SM, Gahl WA, Green ED. Touchman JW, et al. Genome Res. 2000 Feb;10(2):165-73. doi: 10.1101/gr.10.2.165. Genome Res. 2000. PMID: 10673275 Free PMC article.
• Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS).
  Anikster Y, Lucero C, Touchman JW, Huizing M, McDowell G, Shotelersuk V, Green ED, Gahl WA. Anikster Y, et al. Mol Genet Metab. 1999 Feb;66(2):111-6. doi: 10.1006/mgme.1998.2790. Mol Genet Metab. 1999. PMID: 10068513
• CTNS mutations in an American-based population of cystinosis patients.
  Shotelersuk V, Larson D, Anikster Y, McDowell G, Lemons R, Bernardini I, Guo J, Thoene J, Gahl WA. Shotelersuk V, et al. Am J Hum Genet. 1998 Nov;63(5):1352-62. doi: 10.1086/302118. Am J Hum Genet. 1998. PMID: 9792862 Free PMC article.
• CTNS mutations in patients with cystinosis.
  Anikster Y, Shotelersuk V, Gahl WA. Anikster Y, et al. Hum Mutat. 1999;14(6):454-8. doi: 10.1002/(SICI)1098-1004(199912)14:6<454::AID-HUMU2>3.0.CO;2-H. Hum Mutat. 1999. PMID: 10571941 Review.
• [From gene to disease: cystinosis].
  Levtchenko EN, Wilmer M, de Graaf-Hess AC, van den Heuvel LP, Blom H, Monnens LA. Levtchenko EN, et al. Ned Tijdschr Geneeskd. 2004 Mar 6;148(10):476-8. Ned Tijdschr Geneeskd. 2004. PMID: 15042893 Review. Dutch.

Cited by

• Studies with Human-Induced Pluripotent Stem Cells Reveal That CTNS Mutations Can Alter Renal Proximal Tubule Differentiation.
  Thiyagarajan R, Taub M. Thiyagarajan R, et al. Int J Mol Sci. 2023 Nov 30;24(23):17004. doi: 10.3390/ijms242317004. Int J Mol Sci. 2023. PMID: 38069326 Free PMC article.
• Next generation sequencing as second-tier test in high-throughput newborn screening for nephropathic cystinosis.
  Fleige T, Burggraf S, Czibere L, Häring J, Glück B, Keitel LM, Landt O, Harms E, Hohenfellner K, Durner J, Röschinger W, Becker M. Fleige T, et al. Eur J Hum Genet. 2020 Feb;28(2):193-201. doi: 10.1038/s41431-019-0521-3. Epub 2019 Sep 30. Eur J Hum Genet. 2020. PMID: 31570786 Free PMC article.
• The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis.
  Brasell EJ, Chu LL, Akpa MM, Eshkar-Oren I, Alroy I, Corsini R, Gilfix BM, Yamanaka Y, Huertas P, Goodyer P. Brasell EJ, et al. PLoS One. 2019 Dec 4;14(12):e0223954. doi: 10.1371/journal.pone.0223954. eCollection 2019. PLoS One. 2019. PMID: 31800572 Free PMC article.
• Non-invasive intradermal imaging of cystine crystals in cystinosis.
  Bengali M, Goodman S, Sun X, Dohil MA, Dohil R, Newbury R, Lobry T, Hernandez L, Antignac C, Jain S, Cherqui S. Bengali M, et al. PLoS One. 2021 Mar 4;16(3):e0247846. doi: 10.1371/journal.pone.0247846. eCollection 2021. PLoS One. 2021. PMID: 33661986 Free PMC article.
• A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety.
  Langman CB, Greenbaum LA, Sarwal M, Grimm P, Niaudet P, Deschênes G, Cornelissen E, Morin D, Cochat P, Matossian D, Gaillard S, Bagger MJ, Rioux P. Langman CB, et al. Clin J Am Soc Nephrol. 2012 Jul;7(7):1112-20. doi: 10.2215/CJN.12321211. Epub 2012 May 3. Clin J Am Soc Nephrol. 2012. PMID: 22554716 Free PMC article. Clinical Trial.

References

1. 1. Science. 1982 Sep 24;217(4566):1263-5 - PubMed
2. 1. Mol Genet Metab. 1999 Feb;66(2):111-6 - PubMed
3. 1. J Mol Biol. 1990 Oct 5;215(3):403-10 - PubMed
4. 1. Genomics. 1991 May;10(1):94-101 - PubMed
5. 1. Kidney Int. 1992 Nov;42(5):1178-83 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Europe PubMed Central
  • PubMed Central